The Georgia Cancer Center Grand Rounds series features talks on mature cancer-related basic, translational, clinical, or population, prevention, and control research projects.

This series is expected to raise awareness of the great work being done within the Georgia Cancer Center and potentiate expanded interactions and collaborations with colleagues, not just from within the Georgia Cancer Center but from the entire university as well as other institutions.

Our weekly Research in Progress seminar series is a forum for our faculty to present current research from their laboratories. Research areas include basic science/translational, clinical, and behavioral/prevention science related to cancer. The research presented can be at any stage of development, including the earliest stages, where the background and hypotheses are strong, but data are incomplete. The purpose of these talks is to stimulate discussion, generate constructive feedback, and initiate collaboration.


The Medical College of Georgia at Augusta University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


The Medical College of Georgia at Augusta University designates this live activity for a maximum of [number of credits] AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact Us

Education and Training Office

Health Sciences Campus

Georgia Cancer Center - M. Bert Storey Research Building

Lisa Middleton

(706) 721-4566

Series Schedule


Jan. 6, 2021 Lei Zheng, M.D., Ph.D. Co-Director, Pancreatic Cancer Precision Medicine Center of Excellence Program Johns Hopkins Medicine Rationale Behind the Clinical Development of Combination Immunotherapy for Pancreatic Cancer
Jan. 3, 2021 Andrew W. Truman, PhD Assistant Professor, Department of Biological Sciences University of North Carolina at Charlotte "Understanding Hsp70 interactions: new ways to
deal with difficult clients in cancer"
Jan. 20, 2021 Douglas Spitz, PhD Director, Free Radical and Radiation Biology Program University of Iowa Health Care “Targeting Redox Metabolism for Cancer Therapy: From the Bench to the Bedside”
Jan. 27, 2021 Besim Ogretmen, PhD Endowed Chair, SmartState Endowed Chair in Lipidomics and Drug Discovery Medical University of South Carolina "Sphingolipid metabolism and signaling in cancer therapeutics: Implications in aging, neurodegeneration and immunotherapy"
Feb. 3, 2021 Huidong Shi, PhD Professor, Biochemistry and Molecular Biology Georgia Cancer Center "Epigenomics and Single Cell Sequencing Identifies Transcriptional Regulatory Networks That Control Resistance to Exhaustion and Antitumor Activity of CAR-T Cells"
Feb. 10, 2021 Gideon E. Bollag, Ph.D. Chief Executive Officer Plexxikon “Structure Guided Strategies to Optimize Cancer Therapies”
Feb. 17, 2021 Ming Luo, PhD Professor, Department of Chemistry Georgia State University "Armed Oncolytic Virus for Cancer Treatment"
Feb. 24, 2021 Deyu Fang, MD/PhD Hosmer Allen Johnson Professor of Pathology Feinberg School of Medicine, Northwestern University "Sirt1 in immune regulation, inflammation and cancer: a tale of red wine"
March 3, 2021 John W Henson, MD Professor, Department of Neurology Georgia Cancer Center “Genetics and Precision Approaches in Neuro-oncology”
March 10, 2021 Han-Fei Ding, PhD Professor, Pathology Georgia Cancer Center Mapping Cancer Metabolic Dependencies for Therapeutic Targeting
March 17, 2021 Yukai He, MD, PhD Professor, Biochemistry and Molecular Biology Georgia Cancer Center Develop novel CAR-T immunotherapy for hepatocellular carcinoma
March 24, 2021 Ali Arbab, MD, PhD Professor, Biochemistry and Molecular Biology Georgia Cancer Center Engineered Exosomes as Imaging and Therapeutic Probes
March 31, 2021 Leonard M. Neckers, PhD Senior Investigator, Urologic Oncology Branch National Cancer Institute Targeting androgen receptor splice variants with inhibitors of Hsp40 and Hsp70:  A novel approach to treat anti-androgen resistant prostate cancer
April 21, 2021 Said M. Sebti, PhD Associate Director for Basic Research Massey Cancer Center Targeting Oncogenic Signal Transduction Pathways: from Basic Science to Biomarker-Driven Clinical Trials
April 28, 2021 Jianping Huang, MD, PhD Director, Clinical Laboratory Operations Brain Tumor Immunotherapy Program University of Florida Developing effective immunotherapies for patients with cancer
May 5, 2021 Nagla Abdel Karim, MD Thoracic Medical Oncologist Georgia Cancer Center COVID-19 and Lung Cancer
May 12, 2021 Cimona V. Hinton
Professor, Department of Biological Sciences, Center for Cancer Research and Therapeutic Development

Clark Atlanta University GPCR Heterodimers in Metastasis Prevention and as a Metastasis Therapeutic 
May 19, 2021 Charles G. Mullighan, MBBS (Hons), MSc, MD Member, St. Jude FacultyDeputy Director, Comprehensive Cancer Center
Co-Leader, Hematological Malignancies Program
Medical Director, St. Jude Biorepository
William E. Evans Endowed Chair
St. Jude Children's Research Hospital New concepts in resistance to therapy in ALL
June 2, 2021 Hasan Korkaya, DVM, PhD Member, Molecular Oncology & Biomarkers Program Georgia Cancer Center Myeloid cells in the tumor
microenvironment and pre-metastatic
June 9, 2021 Mark James Levis, MD, PhD Program Leader, Hematologic Malignancies and Bone Marrow Transplant Program Sidney Kimmel Comprehensive Cancer Center FLT3 and AML: Slow but steady progress
June 16, 2021 Gurmukh Singh, MD, PhD, MBA, FCAP, CPE, FAAPL Walter L. Shepeard Chair in Clinical Pathology Medical College of Georgia Multiple myeloma: Monoclonal light chains – the sinister immunoglobulin
June 30, 2021 Vahe Heboyan, PhD Director, Health and Behavioral Economics Research Lab Medical College of Georgia Cancer Economics: Health Economics Applications and Models to Aid Cancer Research and Treatment
July 21, 2021 Xinyan Wu, PhD Associate Consultant I, Department of Laboratory Medicine and Pathology Mayo Clinic Proteomics in Cancer Signaling: Dissecting Known Targets and Discovering New Ones
Aug. 18, 2021 Catherine Hedrick, Ph.D. Professor, Center for Autoimmunity and Inflammation, Center for Cancer Immunotherapy La Jolla Institute for Immunology Innate Immune Cells in Cancer Development and Treatment
Sept. 1, 2021 David H. Munn, MD Professor of Pediatric Oncology Georgia Cancer Center Identifying dendritic cell specific checkpoints for targeted immunotherapy
Sept. 15, 2021 Todd Triplett, PhD Assistant Professor The University of Texas at Austin Understanding Immune-Oncology in the Context of Leukemias with Low Mutational Burdens
Sept. 22, 2021 Rachelle W. Johnson, PhD Assistant Professor Vanderbilt-Ingram Cancer Center Addressing the complexities of LIFR signaling in metastatic breast cancer
Sept. 29, 2021 Chang Liu, PhD Research Scientist, Department of Immunology University of Pittsburgh Cracking obstacles both within and outside: Targeting T cel intrinsic- and extrinsic-checkpoints for durable anti-tumore immunity
Oct. 1, 2021 Nagla Abdel Karim, MD Thoracic Medical Oncologist Georgia Cancer Center Disparities in Lung Cancer
Oct. 8, 2021 Avirup Guha, MD, MPH, RPVI, FICOS, FACC Clinical Assistant Professor University Hospitals Current Status and Future Directions in Cardio-Oncology
Oct. 15, 2021 John W Henson, MD Neuro-Oncologist Georgia Cancer Center Advances in Hereditary Cancer Care at the Georgia Cancer Center
Oct. 22, 2021 Locke Bryan, MD Medical Oncologist, Blood Cancers and Disorders Georgia Cancer Center Advances in Hodgkin Lymphoma
Oct. 29, 2021 Kenneth Byrd, MD Head and Neck Oncologist Georgia Cancer Center Salivary Malignancies

Previous Presentations

July 1, 2020 Joseph M. Miano, PhD J. Harold Harrison, MD, Distinguished University Chair in Vascular Biology Augusta University Vascular Biology Center (AU) CRISPR Technology
July 8, 2020 Lauren Byers, MD, MS Associate Professor / Physician Scientist, Department of Thoracic and Head and Neck Medical Oncology MD Anderson Cancer Center Intratumoral Heterogeneity in Lung Cancer - Dissecting Drug Resistance
July 15, 2020 Andrew Futreal BS, PhD Department Chair, Department of Genomic Medicine, Division of Cancer Medicine MD Anderson Cancer Center Cancer heterogeneity – Challenges and Opportunities
July 22, 2020 Charles Sawyers, MD Chair, Human Oncology and Pathogenesis Program Memorial Sloan Kettering Cancer Center Lineage Plasticity and Cancer Drug Resistance
July 29, 2020 James Allison, PhD Chair, Department of Immunology, Division of Basic Science Research MD Anderson Cancer Center Immune Checkpoint Blockade in Cancer Therapy; New Insights into Therapeutic Mechanisms
Aug. 5, 2020 John C. Hardaway, MD, PhD Surgical Oncologist Doctors Hospital of Augusta Regional Delivery of CAR-T; Strategies for Solid Tumor Immunotherapy
Aug. 12, 2020 Daniel de Carvalho, PhD Canada Research Chair, Cancer Epigenetics Princess Margaret Cancer Centre Basic and Translational Aspects of Cancer Epigenetics – From Therapy to Liquid Biopsies
Aug. 19, 2020 Gary A. Piazza, PhD Chief, Drug Discovery Research Center and Abraham A. Mitchell Distinguished Investigator, Professor of Oncologic Sciences and Pharmacology Mitchell Cancer Institute Novel RAS inhibitor class: a few unanswered questions
Aug. 26, 2020 Walter J. Curran, Jr., MD, FACR, FASCO Executive Director Winship Cancer Institute Cancer Care and Research in the Time of COVID
Sept. 2, 2020 Jean-Pierre Issa, MD President and Chief Executive Officer Coriell Institute for Medical Research Next Generation Epigenetic Therapy
Sept. 9, 2020 Yan Cui, PhD Professor, Biochemistry and Molecular Biology Georgia Cancer Center CD73: a Pivotal Immune Checkpoint in the Tumor Microenvironment
Sept. 16, 2020 Keshav K. Singh, PhD Director, Cancer Genetics Program University of Alabama Comprehensive Cancer Center Mito-Nuclear Cross Talk Underlying Cancer 
Sept. 23, 2020 Paulo Rodriguez, PhD Associate Member Moffitt Cancer Center Restoring Protective Anti-tumor Immunity by targeting central mediators of Myeloid and T cell function
Sept. 30, 2020 Wendy Bollag, PhD, FAHA Professor of Physiology, VA Research Career Scientist Medical College of Georgia Phosphatidylglycerol-containing Surfaxin: A Possible Treatment for COVID-19 Pulmonary Failure?
Oct. 7, 2020 Theodore S. Johnson, MD, PhD Associate Professor, Cancer Immunology, Inflammation & Tolerance Georgia Cancer Center IDO-based Multimodal Immuno-radio-chemotherapy for Pediatric Brain Cancer 
Oct. 14, 2020 Vivian Wai Yan Lui, PhD Associate Professor Chinese University of Hong Kong Translational Genomics and Immonogenomics of Head and Neck Cancer
Oct. 21, 2020 Kenneth C. Anderson, MD Program Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics Dana-Farber Cancer Institute Novel Therapies Targeting Myeloma in the Bone Marrow Microenvironment
Oct. 28, 2020 Roni Bollag, MD, PhD Director, Georgia Cancer Center Biorepository Georgia Cancer Center Georgia Cancer Center Biorepository and the statewide Biobankinginitiative (BRAG-Onc) in 2020 
Nov. 4, 2020 Chunhong Yan, PhD Member, Molecular Oncology and Biomarkers Program
Georgia Cancer Center Regulation of Metabolic Stress Response by a Common Stress Sensor
Nov. 11, 2020 Asamoah Bosomtwi, PhD Director, MRI Imaging, Georgia Cancer Center Small Animal Imaging Shared Resource Georgia Cancer Center Quantitative and Qualitative Preclinical Imaging Capabilities at Georgia Cancer Center
Nov. 18, 2020 Anatolij Horuzsko, MD, PhD Professor, Biochemistry and Molecular Biology Georgia Cancer Center TREM1 is a potential target for the treatment of liver diseases
Dec. 2, 2020 Oliver Bogler, PhD Director, Center for Cancer Training National Cancer Institute Funding for Cancer Research Training from the NCI
Dec. 9, 2020 Harikrishna Nakshatri, PhD Marian J. Morrison Professor of Breast Cancer Research Indiana University Impact of genetic ancestry on normal breast heterogeneity and breast cancer biology
Dec. 16, 2020 Dongfang Liu, PHD, MBBS Associate Professor, Department of Pathology, Immunology &Laboratory Medicine, Center for Immunity and Inflammation New Jersey Medical School, Rutgers University Natural Killer Cells: from basic immunobiology to clinical application